Company
Plus Products, Inc.
Headquarters: Vancouver, BC, Canada
CEO: Mr. Jacob F. Heimark
Market Cap
$1.81 Billion
USD as of Sept. 1, 2021
Plus Products, Inc. Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Plus Products Inc. develops, manufactures, and sells cannabis products in California. The company offers cannabis-infused edibles to the regulated medicinal and adult-use, or recreational markets. It sells products under the PLUS brand to dispensaries and delivery service customers. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
Financials
| Last Financial Reports Date | June 30, 2021 |
| Revenue TTM | $13.7 M |
| EBITDA | $-9,243,993 |
| Gross Profit TTM | $5.6 M |
| Profit Margin | -89.54% |
| Operating Margin | -68.14% |
| Quarterly Revenue Growth | -12.20% |
Stocks & Indices
Plus Products, Inc. has the following listings and related stock indices.
Stock: OTC: PLPRF wb_incandescent
Stock: CSE: PLUS wb_incandescent
Stock: FSX: 0T1 wb_incandescent